2-69518983-A-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_014911.5(AAK1):ā€‹c.1468T>Cā€‹(p.Tyr490His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000644 in 1,397,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000064 ( 0 hom. )

Consequence

AAK1
NM_014911.5 missense

Scores

1
5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.56
Variant links:
Genes affected
AAK1 (HGNC:19679): (AP2 associated kinase 1) This gene encodes a member of the SNF1 subfamily of serine/threonine protein kinases. Adaptor-related protein complex 2 (AP-2 complexes) functions during receptor-mediated endocytosis to trigger clathrin assembly, interact with membrane-bound receptors, and recruit encodytic accessory factors. The encoded protein interacts with and phosphorylates a subunit of the AP-2 complex, which promotes binding of AP-2 to sorting signals found in membrane-bound receptors and subsequent receptor endocytosis. Its kinase activity is stimulated by clathrin. This kinase has been shown to play an important role in regulating the clathrin-mediated endocytosis of the rabies virus, facilitating infection. Inhibitors of this kinase are being studied as candidate therapeutics to disrupt the entry of viruses, including SARS-CoV-2, into target cells. It is also involved in positive regulation of Notch pathway signaling in mammals. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21382046).
BS2
High AC in GnomAdExome4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AAK1NM_014911.5 linkuse as main transcriptc.1468T>C p.Tyr490His missense_variant 12/22 ENST00000409085.9 NP_055726.4 Q2M2I8-1
AAK1NM_001371575.1 linkuse as main transcriptc.1468T>C p.Tyr490His missense_variant 12/21 NP_001358504.1
AAK1NM_001371577.1 linkuse as main transcriptc.1468T>C p.Tyr490His missense_variant 12/15 NP_001358506.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AAK1ENST00000409085.9 linkuse as main transcriptc.1468T>C p.Tyr490His missense_variant 12/225 NM_014911.5 ENSP00000386456.3 Q2M2I8-1
AAK1ENST00000406297.7 linkuse as main transcriptc.1468T>C p.Tyr490His missense_variant 12/181 ENSP00000385181.3 Q2M2I8-2
AAK1ENST00000606389.8 linkuse as main transcriptc.1468T>C p.Tyr490His missense_variant 12/185 ENSP00000485350.2 A0A096LP25
AAK1ENST00000409068.5 linkuse as main transcriptc.1468T>C p.Tyr490His missense_variant 12/152 ENSP00000386342.1 E9PG46

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000644
AC:
9
AN:
1397092
Hom.:
0
Cov.:
32
AF XY:
0.00000871
AC XY:
6
AN XY:
689032
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000742
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 10, 2024The c.1468T>C (p.Y490H) alteration is located in exon 12 (coding exon 11) of the AAK1 gene. This alteration results from a T to C substitution at nucleotide position 1468, causing the tyrosine (Y) at amino acid position 490 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Uncertain
0.026
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
24
DANN
Benign
0.95
DEOGEN2
Benign
0.048
T;T;.
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.37
T;T;T
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.21
T;T;T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
1.7
.;L;L
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.61
N;N;N
REVEL
Benign
0.15
Sift
Uncertain
0.019
D;D;D
Sift4G
Benign
0.54
T;T;T
Polyphen
0.99, 1.0
.;D;D
Vest4
0.32
MutPred
0.20
Loss of phosphorylation at Y490 (P = 0.0568);Loss of phosphorylation at Y490 (P = 0.0568);Loss of phosphorylation at Y490 (P = 0.0568);
MVP
0.66
MPC
0.46
ClinPred
0.60
D
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.093
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr2-69746115; API